Positron emission tomography (PET) using 18fluoro-2-deoxyglucose (FDG) has become a standard clinical tool for staging and response assessment in aggressive lymphomas. response at end of treatment correlates with end result in DLBCL. Optimal technical criteria for standardization of acquisition and…